Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Withdrawn × Glioblastoma × Clear all

Phase

Phase 2 22 Phase 1 19 Phase NA 9 Phase 1/2 6 Phase EARLY_PHASE1 4 Phase 3 3 Phase 2/3 2 Phase 4 1

Status

Active not recruiting 2 Withdrawn 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Neoplasms 8 Polycystic Ovary Syndrome 7 Infertility 4 Pain, Postoperative 3 Liver Neoplasms 3 Urinary Bladder Neoplasms 2 Recurrence 2 Pulmonary Embolism 2 Neuroma, Acoustic 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma, Follicular 2 Lung Neoplasms 2 Leiomyoma 2 Inflammation 2 Head and Neck Neoplasms 2 Febrile Neutropenia 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Bites and Stings 2 Anovulation 2 Vomiting 1 Venous Thrombosis 1 Venous Thromboembolism 1 Unipolar Major Depression 1 Surgical Wound Infection 1 Stomatitis 1 Stomach Neoplasms 1 Sleep Initiation and Maintenance Disorders 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05900908 2025-04-10

PATHWAyS

GT Medical Technologies, Inc.

Phase 4 Withdrawn

Glioblastoma, Neoplasm Metastasis, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡